Kong, P., Kong, P., Kong, P., Jiao, Y., Jiao, Y., Sun, M., . . . Song, B. SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationKong, Pengzhou, et al. SECTM1 Acts as an Immune-related Biomarker of Poor Prognosis and Promotes Cancer Progression by Modulating M2 Macrophage Polarization in Esophageal Squamous Cell Carcinoma. Frontiers Media S.A.
MLA (9th ed.) CitationKong, Pengzhou, et al. SECTM1 Acts as an Immune-related Biomarker of Poor Prognosis and Promotes Cancer Progression by Modulating M2 Macrophage Polarization in Esophageal Squamous Cell Carcinoma. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.